Cargando…
Assessment of In Vivo and In Vitro Genotoxicity of Glibenclamide in Eukaryotic Cells
Glibenclamide is an oral hypoglycemic drug commonly prescribed for the treatment of type 2 diabetes mellitus, whose anti-tumor activity has been recently described in several human cancer cells. The mutagenic potential of such an antidiabetic drug and its recombinogenic activity in eukaryotic cells...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372363/ https://www.ncbi.nlm.nih.gov/pubmed/25803314 http://dx.doi.org/10.1371/journal.pone.0120675 |